Home Business 12 Well being Care Shares Shifting In Monday’s Intraday Session – Altimmune (NASDAQ:ALT), ASLAN Pharma (NASDAQ:ASLN)

12 Well being Care Shares Shifting In Monday’s Intraday Session – Altimmune (NASDAQ:ALT), ASLAN Pharma (NASDAQ:ASLN)

0
12 Well being Care Shares Shifting In Monday’s Intraday Session – Altimmune (NASDAQ:ALT), ASLAN Pharma (NASDAQ:ASLN)

[ad_1]

Gainers

  • EyePoint Prescribed drugs EYPT inventory rose 172.8% to $18.03 throughout Monday’s common session. The corporate’s market cap stands at $636.6 million.
  • Alterity Therapeutics ATHE inventory elevated by 122.28% to $3.69. The market worth of their excellent shares is at $15.0 million.
  • Altimmune ALT inventory rose 34.98% to $4.82. The market worth of their excellent shares is at $258.9 million.
  • CEL-SCI CVM inventory elevated by 34.3% to $2.78. The corporate’s market cap stands at $138.9 million.
  • Lucy Scientific Discovery LSDI shares rose 31.68% to $0.28. The corporate’s market cap stands at $4.8 million.
  • Biomea Fusion BMEA shares elevated by 30.33% to $21.74. The corporate’s market cap stands at $776.2 million.

Losers

  • NexImmune NEXI shares fell 33.7% to $4.01 throughout Monday’s common session. The market worth of their excellent shares is at $4.2 million.
  • BioAtla BCAB inventory fell 20.63% to $1.41. The corporate’s market cap stands at $67.3 million.
  • Vivos Therapeutics VVOS shares fell 20.22% to $15.88. The corporate’s market cap stands at $21.1 million.
  • Conduit Prescribed drugs CDT inventory declined by 18.34% to $4.5. The market worth of their excellent shares is at $327.6 million.
  • OneMedNet ONMD shares fell 15.47% to $3.5. The corporate’s market cap stands at $112.9 million.
  • ASLAN Pharma ASLN inventory fell 15.08% to $0.54. The corporate’s market cap stands at $8.9 million.
    See Additionally: www.benzinga.com/cash/best-healthcare-stocks/

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.


[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here